title: [Optimization of hypotensive therapy in hospitals].
abstract: The authors offer a scheme of optimizing hypotensive treatment, which combines subjective, objective (the hemodynamics) and social (ability to work) characteristics. It was shown that the criteria of the adequacy and efficacy of hypotensive treatment should include the intensity of the cerebral blood flow and the level of blood pressure in addition to the coefficient of information processing, and an increase in the systolic and diastolic blood pressure. The use of the offered scheme of optimization in 80 patients with essential hypertension made it possible to cut down the period of hospitalization and improve the efficacy of treatment.
authors.forename: G I
authors.initials: GI
authors.lastname: Sidorenko
authors.forename: A I
authors.initials: AI
authors.lastname: Pavlova
authors.forename: T A
authors.initials: TA
authors.lastname: Nechesova
authors.forename: V M
authors.initials: VM
authors.lastname: Al'khimovich
authors.forename: V N
authors.initials: VN
authors.lastname: Gaĭduk
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002560:Cerebrovascular Circulation; D003000:Clonidine / Q000627:therapeutic use*; D004338:Drug Combinations / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use*; D006852:Hydrochlorothiazide / Q000627:therapeutic use*; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology; D008297:Male; D009483:Neuropsychological Tests; D012110:Reserpine / Q000627:therapeutic use*
chemical_list: D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004338:Drug Combinations; C005166:dihydralazine - hydrochlorothiazide - reserpine drug combination; D006852:Hydrochlorothiazide; D006830:Hydralazine; D012110:Reserpine; D003000:Clonidine
vernacular_title: Optimizatsiia gipotenzivnoĭ terapii v usloviiakh statsionara.